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Abstract
Background: Small colony variants (SCVs) are slow-growing bacteria, which often show increased resistance to antibiotics
and cause latent or recurrent infections. It is therefore important to understand the mechanisms at the basis of this
phenotypic switch.
Methodology/Principal Findings: One SCV (termed PAO-SCV) was isolated, showing high resistance to gentamicin and to
the cephalosporine cefotaxime. PAO-SCV was prone to reversion as evidenced by emergence of large colonies with a
frequency of 10
25 on media without antibiotics while it was stably maintained in presence of gentamicin. PAO-SCV showed
a delayed growth, defective motility, and strongly reduced levels of the quorum sensing Pseudomonas quinolone signal
(PQS). Whole genome expression analysis further suggested a multi-layered antibiotic resistance mechanism, including
simultaneous over-expression of two drug efflux pumps (MexAB-OprM, MexXY-OprM), the LPS modification operon
arnBCADTEF, and the PhoP-PhoQ two-component system. Conversely, the genes for the synthesis of PQS were strongly
down-regulated in PAO-SCV. Finally, genomic analysis revealed the presence of mutations in phoP and phoQ genes as well
as in the mexZ gene encoding a repressor of the mexXY and mexAB-oprM genes. Only one mutation occurred only in REV, at
nucleotide 1020 of the tufA gene, a paralog of tufB, both encoding the elongation factor Tu, causing a change of the rarely
used aspartic acid codon GAU to the more common GAC, possibly causing an increase of tufA mRNA translation. High
expression of phoP and phoQ was confirmed for the SCV variant while the revertant showed expression levels reduced to
wild-type levels.
Conclusions: By combining data coming from phenotypic, gene expression and proteome analysis, we could demonstrate
that resistance to aminoglycosides in one SCV mutant is multifactorial including overexpression of efflux mechanisms, LPS
modification and is accompanied by a drastic down-regulation of the Pseudomonas quinolone signal quorum sensing
system.
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Introduction
Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium
found in diverse ecological habitats such as soils, marshes and
coastal marine waters. As an opportunistic pathogen, P. aeruginosa
is able to infect humans, animals and plants [1,2,3]. P. aeruginosa is
a primary nosocomial diseases causative agent and represents the
major cause of morbidity and mortality in patients with cystic
fibrosis (CF). P. aeruginosa produces a large panel of secreted
virulence factors like the phenazine pyocyanin, the siderophore
pyoverdine, elastase, and toxins. It is also characterized by its high
level of drug resistance involving the formation of antibiotic-
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variants [2,3]. During the course of infection, P. aeruginosa can
efficiently adopt diverse strategies to evade antimicrobial stresses
and the host immune system defenses, making it impossible to
eradicate this bacterium permanently from CF lungs [2,4].
Important phenotypic variations can occur during chronic
colonization, such as conversion to mucoidy [5], the emergence
of persister cells after antibiotics treatment [6,7] or the occurrence
of small colony variants with higher resistance to antibiotics
[8,9,10,11,12]. Compared to wild-type P. aeruginosa, SCVs show
increased antibiotic resistance, enhanced biofilm formation,
reversion to wild-type-like morphotypes, reduced motility, and
slow and auto-aggregative growth behavior [13,14]. SCVs have
been isolated from CF lungs or sputum [4,8,9,12], laboratory-
grown biofilms [11,12,14], in vitro selection upon antibiotic
exposure [15,16] or as a consequence of gene inactivation
[17,18]. Clinically, P. aeruginosa SCVs have already been proven
to associate with chronic infections behaving as persisters in
pathogenesis of CF patients and making it almost impossible for
clinicians to eradicate the infections [8,19,20]. The intracellular
second messenger cyclic-di-GMP (c-di-GMP) [21] has been
recently shown to be involved in SCV phenotype switching in
terms of biofilm formation, reduced motility, and exopolysacchar-
ide (EPS) production [18,22,23,24,25,26]. The ‘‘phenotypic
variant regulator’’, PvrR, containing a conserved EAL domain
of phosphodiesterase (PDE) involved in the hydrolysis of c-di-
GMP, has been identified to control the phenotypic switch from
an antibiotic resistant and auto-aggregative rough SCV (RSCV) of
P. aeruginosa strain PA14 to wild-type-like antibiotics susceptible
revertants [15]. Another characteristic driven by the elevated level
of c-di-GMP in SCVs is the contribution of two EPS-encoding loci
in some P. aeruginosa strains (PA2231-PA2245 for psl and PA3058-
PA3064 for pel) to auto-aggregation and hyper adherence
phenotypes characterized by increased Congo Red dye binding
[27,28,29]. Although antibiotics resistance of P. aeruginosa has been
connected to biofilm formation and linked to phenotypic variation
[15], the mechanisms underlying the extremely high antibiotic
resistance of SCVs has not been reported extensively due to the
unavailability, in some cases, of the WT counterpart for
comparison.
In this study, we present the identification of a novel, reversion-
prone, P. aeruginosa SCV with distinct features, including resistance
to various antibiotics, defective motility, and absence of production
of the quorum sensing PQS signal molecule. Using a combination
of genomic, transcriptomic, proteomic and phenotypic approach-
es, we provide the first evidence of concerted mechanisms
harnessed by this P. aeruginosa SCV leading to antibiotic resistance
as well as down-regulation of acute virulence genes, probably
involving the PhoP PhoQ two component system.
Results
Phenotypic characterization of a gentamicin-resistant
P. aeruginosa PAO1-SCV and large colony
pseudo-revertants
Following sub-culturing P. aeruginosa PAO1 (ATCC 15692) in
the presence of high-concentration of gentamicin (200 mgm l
21,
Gm), we isolated a Gm-resistant SCV designated PAO-SCV,
which formed small (ca. 1/5 of the wild-type diameter), smooth
colonies after three days of incubation at 37uC on LB agar plates
(Figure 1A). PAO-SCV grown in liquid LB also showed a delayed
entry in exponential phase compared to the wild-type (Figure 1B).
PAO-SCV showed high level of resistance towards gentamicin
and cefotaxime (Table 1 and Figure 2). The persistence fraction of
PAO-SCV after treatment with the fluoroquinolone antibiotic
ofloxacin was approximately 2-fold higher compared to the PAO1
wild-type strain (Figure S1).
In the absence of Gm large colonies variants tended to appear,
characterized by rough contours, at a frequency of 10
25 (Figure 1A
and Figure 2) on agar plates. The frequency of reversion varied
between 1.3610
25 to 8.7610
25 depending on the medium used
(LB or CAA) or the incubation temperature (25uCo r3 7 uC).
Importantly, no large colonies appeared when the PAO-SCV was
grown in the presence of Gm since the cells from large colonies
regained Gm and cefotaxime sensitivity (Figure 2). Given its
unstable character, PAO-SCV was kept on LB plates supplement-
ed with Gm (200 mgm l
21) to avoid the emergence of pseudo-
revertants. However, during experiments described below no
antibiotic was added (unless mentioned in the text) in order to
Figure 1. Growth phenotypes of PAO-SCV. A: Comparison of the
sizes of colonies from wild-type (left), PAO-SCV (middle), and a large
colony variant originating from PAO-SCV (right). The large colony
variant shows evidence of autolysis. B: Growth of wild-type (N) and
PAO-SCV (#) in LB liquid medium measured in the Bioscreen.
doi:10.1371/journal.pone.0029276.g001
Table 1. Minimal inhibitory concentrations (MICs) of different
antibiotics against wild type (PAO), PAO-SCV and one selected
pseudo-revertant (REV).
Antibiotic PAO PAO-SCV REV
Piperacillin 8 8 8
Cefotaxime 16 32 16
Ceftazidime 4 4 4
Imipenem 8 8 ,=1
Meropenem 4 2 0.5
Gentamicin ,=1 .16 8
Ciprofloxacin ,0.25 ,0.25 ,0.25
Levofloxacin 1 0.5 1
doi:10.1371/journal.pone.0029276.t001
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SCV phenotype. At the end of experiments cell suspensions were
diluted and the number of large colonies counted. When their
number was less than 1/10
5 the experiment was considered to be
valid.
PQS production is strongly decreased in PAO-SCV
We observed that the small colony variant showed reduced
production of some known quorum sensing-dependent virulence
factors (pyocyanin, pyoverdine, elastase, and a total absence of
motility [Figure S2]). Likewise, the PAO-SCV showed strongly
reduced virulence using both plants (Belgian endive) and Drosophila as
hosts (Figure S3). This prompted us to look at the production of
quorum sensing signal molecules themselves, including N-3-(oxodo-
decanoyl)-L-homoserine lactone (3-oxo-C12-HSL) for the LasR–LasI
system and N-butyryl-L-homoserine lactone (C4-HSL) for the RhlR–
RhlI system [30,31]. Finally, we also checked the production of 4-
quinolones such as 2-heptyl-4-quinolone (HHQ) and 2-heptyl-3-
hydroxy-4-quinolone (PQS) [32]. The levels of 3-oxo-C12-HSL and
C4-HSL in the cell culture supernatants were similar for the wild-
type, PAO-SCV and the pseudo-revertant (results not shown).
However, in PAO-SCV a strong decrease in the production of both
HHQ and PQS was observed as compared to that of wild-type while
the wild type level was restored in the pseudo-revertant (Figure 3).
Comparison of proteome profiles of PAO-SCV and
wild-type P. aeruginosa
Because profound phenotypic changes were detected in PAO-
SCV, we decided to compare the proteomes of PAO-SCV and
wild-type cells (Figure 4). After protein identification with MALDI-
TOF MS analysis, we found at least 24 differentially expressed
proteins, whereby 16 proteins were less abundant and 8 more
abundant in PAO-SCV (Table 2). The proteins showing
differential abundance are involved in amino acid biosynthesis
and metabolism, motility, transport of small molecules and
transcriptional regulation. According to this analysis, the two-
component response regulator PhoP is one of the most
prominently induced proteins in PAO-SCV. Another finding is
the over-expression of the major outer membrane protein OprF in
PAO-SCV, which is the P. aeruginosa major non-specific porin
allowing diffusion of various solutes, such as nitrates or nitrites
under anaerobic conditions or small oligosaccharides with a
molecular weight up to 1519 Da [33,34]. We also found decreased
expression of the anaerobiosis-induced outer membrane porin
OprE, which, similarly to OprD, was predicted to be involved in
outer membrane permeability of the b-lactam antibiotic imipenem
and basic amino acids [35,36]. The SCV proteome showed a
drastic decrease in the production of the translation elongation
factor Tu, TufB (PA4277) and a less marked decrease in
elongation factor Ts (Tsf, PA3655).
Genome-wide transcriptional profile of PAO-SCV and
PAO1
Since some of the differentially produced proteins could already
give clue to the changes occurring in the SCV mutant, we decided
to further investigate which global changes in gene expression
could account for this phenotypic variation. The gene transcrip-
tion profiles of PAO-SCV and WT strains were compared in early
and late stationary-phase of growth, corresponding to incubation
times of 20 and 40 h respectively, using P. aeruginosa Affymetrix
GeneChips. The results are presented using Venn diagrams and
pie charts for simplicity, facilitating the understanding and
interpretation of the overall genome transcriptional profile [37].
The tables showing the complete lists of differentially expressed
genes are shown as supplementary material (Tables S1, S2, S3, S4
and S5). As shown in Figure 5 and in supplementary Tables S1,
S2, S3, S4 and S5), during stationary phase, a total of 642 genes
representing approximately 12% of the entire genome displayed a
differential expression pattern in PAO-SCV compared to that of
wild type PAO1 (P value ,0.05, Student’s t-test). Among these 642
genes, 466 were up-regulated (< 73% of differentially regulated
genes, from 2- to 26-fold, see Table S3) and 176 were down-
regulated (< 27% of differentially regulated genes, from 2- to 16-
fold, see Table S4). Interestingly, remarkable differences were
observed for up-regulated genes (Figure 5B), among which 356
genes were found to be highly expressed during late stationary
phase while only 164 genes were up-regulated during early
stationary phase as compared to the wild-type. Genes involved in
amino acid biosynthesis and metabolism showed an increased
transcription level in both early and late stationary phase of
Figure 2. Sensitivity to antibiotics of wild-type, PAO-SCV, and
PAO-REV. Sensitivity to gentamicin (A) and cefotaxime (B) of wild type
PAO1 (left), PAO-SCV (middle), and one pseudo-revertant (right). The
pseudo-revertant and wild-type are sensitive to both antibiotics while
PAO-SCV is resistant. Notice the presence of large colonies in the
bacterial lawns corresponding to PAO-SCV.
doi:10.1371/journal.pone.0029276.g002
Figure 3. Production of signal molecules. Detection of HHQ and
PQS: lane 1: wild-type supernatant from a stationary phase culture in LB,
lane 2: same, but from another culture, lane 3 and 4: PAO-SCV
supernatant.
doi:10.1371/journal.pone.0029276.g003
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resistance and genes coding for membrane proteins were highly
expressed in the SCV mutant in early stationary phase.
Conversely, some genes involved in the production of secreted
factors and those related to phage, transposon and plasmids were
expressed at a lower level in PAO-SCV compared to the wild-type.
Figure 6A shows that some of the genes known to be involved in
antibiotic resistance are up-regulated in the PAO-SCV. These
could be classified into four different functional groups, linked to
four distinct resistance mechanisms (See lists of selected genes in
Table S3). Among these are efflux pump systems genes known to
contribute to resistance to aminoglycosides, including mexAB-oprM
and mexXY and their respective mexR and mexZ regulatory genes
[38]. The observed higher expression of these efflux pumps is in
agreement with the results showing a higher resistance to all
aminoglycosides and to the cephalosporin antibiotic cefotaxime
(Figure 2 and Table 1). We also found that the cat gene encoding
the chloramphenicol acetyl transferase is up-regulated in PAO-
SCV, both in exponential and stationary phase. Interestingly,
expression of another resistance-nodulation-cell division (RND)
efflux pump, MexGHI-OpmD, is reduced in PAO-SCV in late
stationary phase. This efflux system has been shown to be
important for PQS-mediated signaling, pyocyanin production, and
is thought to be a general phenazine transporter, including
pyocyanin [39,40,41]. Again, this observation is in line with the
reduced production of pyocyanin by PAO-SCV and the quasi-
absence of HHQ and PQS in culture supernatants (Figure 3).
Among PAO-SCV up-regulated genes are those involved in LPS
modification, including migA (PA0705) encoding a glycosyl
transferase, and the gene cluster PA3552-PA3559 (arnBCADTEF-
PA3559, Figure 6B), which are homologues of the pmrHFIJLKM
genes of Salmonella enterica involved in lipid A modification
[42,43,44]. Interestingly, phoP-phoQ, together with the upstream
porin protein gene oprH was markedly up-regulated throughout
the stationary phase in PAO-SCV, forming the third functional
group, and explaining the overexpression of migA and arnBCAD-
TEF-PA3559 (Figure 6C). As already mentioned, higher levels of
the transcriptional regulator PhoP were also detected by 2D-
PAGE analysis. The PhoP-PhoQ system is known to be involved
in aminoglycoside resistance in P. aeruginosa [45].
A fourth functional group of genes markedly up-regulated in
PAO-SCV included those encoding membrane proteins, tran-
scriptional regulators and transporters of small molecules
(Figure 6D). More specifically, several genes encoding outer
membrane proteins are up-regulated in PAO-SCV: the previously
mentioned oprH, oprD, PA1198 (encoding a lipoprotein), oprQ,
opdQ, opdP, and the lipoprotein gene omlA. OprQ, and OpdP
belong to the OprD family and have been proposed to contribute
to the transport of arginine [46]. In this context, it is interesting to
note that the genes PA5152 (ABC transporter, ATP binding
component), and, to a large extent, PA5153 (periplasmic binding
protein), probably involved in the transport of arginine, are also
up-regulated.
The transcriptome analysis not only provided insights into the
PAO-SCV mechanisms involved in aminoglycoside-resistance, but
also explained some of the prominent phenotypic changes. As
shown in Figure 7A, transcript levels of the pqsABCDE genes as
well as for the two neighboring anthranilate synthase genes phnA
and phnB were strongly reduced in PAO-SCV, in line with the
results presented in Figure 3 showing a strong decrease in HHQ
Figure 4. Comparison of proteomes of wild-type and PAO-SCV. 2-D gel electrophoresis of soluble proteins from wild-type and from PAO-SCV
grown in LB medium till stationary phase. Spots showing differences are indicated as well as the corresponding PA gene number. See Table 2 for
details.
doi:10.1371/journal.pone.0029276.g004
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genes (pqsA-E, pqsH, phnAB), genes such as lasA (coding for
elastase), phzC2-G2, phzB1, phzS (for pyocyanin biosynthesis), hcnC
(for HCN production) and rhlA (for rhamnolipids synthesis) were
also down-regulated. Lower rhamnolipid production could also
partly explain the observed decreased swarming motility and the
absence of channels in PAO-SCV biofilms [47,48]. In agreement
with the absence of changes in AHLs production, the transcription
of lasI and rhlI coding for the 3-oxo-C12-HSL and C4-HSL
synthases was unchanged.
Some genes involved in energy generation via respiration were
also differentially regulated since we observed a higher expression
in PAO-SCV of cytochromes genes such as PA0105-0108
(encoding cytochrome c oxidase subunits I–III), PA1175-1177
(napDFE encoding the components of nitrate reduction), and a
marked up-regulation of PA1983 (exaB, encoding a cytochrome
c550). Other genes involved in energy generation were found
down-regulated in PAO-SCV such as PA4133 (ccoN).
Another interesting finding is the differential expression of genes
associated with biofilm formation. We found that in PAO-SCV,
flagellar synthesis genes expression was reduced compared to wild-
type PAO1 which was also confirmed by proteomic analysis (see
Figure 5 and Table 2). This result could explain the total absence
of motility of PAO-SCV (Figure S2). The third interesting
functional group is formed by phage-related genes including
phage those involved in Pf1 phage production and the PA0616-
PA0647 cluster, the expression of which was greatly reduced in
PAO-SCV compared to wild-type (Figure 7C).
Validation of microarray results via Quantitative RT PCR
Quantitative real time PCR was used to measure the level of
transcripts of the phoP and phoQ genes in wild type, SCV, and
one pseudo-revertant. As shown in Figure 8, the level of phoP
and phoQ transcription was increased in the SCV while the levels
were similar for wild-type and t h er e v e r t a n tl a r g ec o l o n y
variant.
Table 2. Identification of differentially produced proteins in P. aeruginosa PAO-SCV by MALDI-TOF MS peptide mass mapping
(PMP).
PA No. Gene Protein identification
Matched
peptides
Sequence
coverage (%)
Total mass
(Da) Localization* pI value
Down in SCV
PA0344 Hypothetical protein 21 47 50,498 Cyt 6.8
PA4273 rplA 50S ribosomal protein L1 9 80 93,130 Cyt 8.3
PA5100 hutU Urocanase 34 51 61,554 Cyt 6.0
PA2300 chiC Chitinase 25 53 53,066 Extr 5.2
PA5171 arcA Arginine deiminase 22 52 46,806 Cyt 5.5
PA5171 arcA Arginine deiminase 25 63 46,675 Cyt 5.5
PA4277 tufB Elongation factor Tu 25 68 43,684 Cyt 5.2
PA0291 oprE OprE porin 27 60 49,637 OM 8.7
PA1087 flgL Flagellar hook-associated protein 20 53 47,020 Extr 6.0
PA1337 ansB Glutaminase-asparaginase 22 60 38,620 Per 6.7
PA0956 proS Prolyl-tRNA synthetase 22 37 65,536 Cyt 6.1
PA3655 tsf Elongation factor Ts 27 77 30,691 Cyt 5.2
PA4708 phuT Heme-transport protein 19 68 31,019 Per 6.9
PA5505 Probable TonB-dependent receptor 20 69 28,048 OM 7.8
PA0139 ahpC Alkyl hydroperoxide
reductase subunit C
18 66 20,643 Cyt 5.9
PA3326 Endopeptidase Clp chain P 18 70 22,128 Cyt 5.4
Up in SCV
PA4502 Probable binding protein
component of ABC transporter
19 31 58,860 Peri 6.2
PA0852 cbpD Chitin-binding protein
CbpD precursor
18 45 42,347 Extr 6.4
PA1074 braC Branched-chain amino acid
transport protein BraC
23 70 39,858 Peri 5.6
PA3655 tsf Elongation factor Ts 27 83 30,691 Cyt 5.2
PA0395 pilT Twitching motility protein PilT 16 56 41,644 OM 7.2
PA4495 Hypothetical protein 16 55 24,921 Peri 5.8
PA1179 phoP Two-component response
regulator PhoP
18 71 25,748 Cyt 5.3
PA1777 oprF OprF 17 75 23,270 OM 4.8
*Cyt=cytoplasm, Peri=periplasm, IM=inner membrane, OM=outer membrane, Extr=extracellular.
doi:10.1371/journal.pone.0029276.t002
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The genome of the originally selected pseudo-revertant (REV)
of PAO-SCV was fully sequenced using the Illumina Genome
Analyzer. The choice to re-sequence the revertant only was
justified by the fact that it should contain all mutations present in
three strains (PAO1, PAO-SCV, revertant), and indels and single
nucleotide polymorphisms (SNPs) could be easily checked for
their presence in the genomes of PAO-SCV and its clonal wild-
type using a combination of PCR amplification and Sanger
sequencing. A limited list of sequence variations in relation to the
PAO1 sequence was found (Table 3), most of which were already
detected when we re-sequenced these regions in our own PAO1
lab strain and in the PAO1 strain of Chronic Pseudomonas
Infection Group in Helmholtz Infection Research Centre [49]. In
order to exclude the possibility that genetic variations have been
overlooked due to the limitations of reference based read
mapping, the reads were additionally assembled in a de novo
approach using Velvet and the resulting contigs were aligned with
the PAO1 genome to find genetic variations. Finally, eight
changes remained that were unique to REV after elimination of
the mutations also found in PAO1 wild-type (Table 3). For seven
of these regions, PCR amplification and re-sequencing via the
Sanger method revealed that these differences in sequence were
present in both REV and SCV. In only one instance, a mutation
was found that was unique to REV, causing a base change at
position 1020 of the tufA gene (PA4277), a paralog of tufB
(PA4265). The two genes are nearly identical in sequence, except
at this position where tufB has a GAC codon for aspartate while
tufa has the rarely used codon GAT at the same place. In REV, a
mutation caused a silent mutation in tufA, changing the GAT
codon to GAC, like in the tufB gene. However, no additional
variations were identified and all contigs aligned to at least one
genomic region of PAO1 excluding the possibility of an
unrecognized insertion of exogenous genetic elements (e.g.,
phages or transposons). The detection of genetic variations
usually assumes a clonal population and SNPs and indels of low
abundance are mostly interpreted as sequencing errors and
excluded from the analysis. Nevertheless, the absence of REV
specific mutations (except in one case) may be due to several
mutations that independently cause the phenotypic conversion
and are present in different clones coexisting in a mixed
population. The original data were therefore re-analyzed to
identify SNPs and indels that were present in at least 10% of the
reads. However, this analysis also identified only those variations
that were already detected in the initial approach.
Interestingly, changes were identified in phoPQ and mexZ, in line
with the results of the transcriptional analysis. Specifically, the phoP
gene contains a SNP which confers a histidine (H) to arginine (R)
Figure 5. Transcriptome analysis. A: Comparison of up-regulated and down-regulated genes in PAO-SCV in early stationary phase (ESP) and in
late stationary phase (LSP). B: Repartition of up- and down-regulated genes in function of genes categories (color coded).
doi:10.1371/journal.pone.0029276.g005
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in its coding sequence, deleting a 13 amino acids sequence
RLLRSEHKQRERY between residues 226 and 239. In PAO-
SCV the mexZ gene was inactivated by the introduction of a stop
codon, which could explain the over-expression of the MexXY
pump involved in aminoglycosides and fluoroquinolone resistance.
Figure 6. Analysis of differentially expressed genes involved in transport, efflux, and membrane modification. A: Differentially
expressed genes corresponding to efflux systems. The mexXY and mexAB-oprM genes are up-regulated while the mexGHI-opmD genes are down-
regulated in PAO-SCV. B: Up-regulation of the arnBCADTEF-PA3559 operon for lipid A modification in PAO-SCV. C: Up-regulation of oprH-phoPQ
operon in PAO-SCV. D: Hierarchical clustering of differentially-expressed genes in PAO-SCV corresponding to membrane proteins, transcriptional
regulators, and transporters.
doi:10.1371/journal.pone.0029276.g006
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The SCV phenotype observed in this study is reminiscent of the
observations made by Tarighi et al. who found that knocking out
the the ppgL gene (PA4204) of P. aeruginosa caused a SCV
phenotype with the apparition of large colony variants [17]. In this
particular case the SCV phenotype was thought to be due to the
accumulation of a toxic intermediate: gluconolactone [17]. This
observation suggests that SCV phenotypes can be the results of
exposures to different stresses. In P. aeruginosa, several mechanisms
of aminoglycoside resistance have been described: resistance
through efflux systems, by alteration of porins or outer membrane
properties (including LPS modification), resistance through
chromosomal mutations of regulatory genes, and resistance
through enzymatic drug modification, including both intrinsic
and acquired resistance [50,51,52,53,54,55]. P. aeruginosa can use
these mechanisms in combination, to reach high-level of resistance
to certain antibiotics, which is precisely what we observed in this
study since we found an overexpression of two efflux systems
(MexXY-OprM, MexAB-OprM, increased expression of the
Figure 7. Analysis of down-regulated genes in PAO-SCV. A: Down-regulation of quorum-sensing-regulated genes in PAO-SCV: pqsABCDE-
phnAB for the biosynthesis of PQS, the two phenazine biosynthesis operons (phz), the rhamnolipid production rhlA gene, and the hydrogen cyanide
production gene (hcn). B: Up-regulation of pyochelin siderophore biosynthesis (pch) and uptake (fptA) genes in PAO-SCV. C: Down-regulation of two
phage-related clusters of genes in PAO-SCV.
doi:10.1371/journal.pone.0029276.g007
Figure 8. Analysis of phoP and phoQ gene expression. Quantitative real time PCR analysis of phoP and phoQ gene expression in wild type
PAO1, in PAO-SCV, PAO-SCV grown in the presence of Gm (20 mg ml).
doi:10.1371/journal.pone.0029276.g008
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OprH, OprF, and decreased expression of OprE. The tripartite
efflux pump MexXY-OprM is known to be a major contributor to
aminoglycoside resistance in P. aeruginosa [56,57,58,59] as well as
the efflux of the drug tigecycline [60]. In addition, MexAB-OprM
was also proven to confer resistance to b-lactams, fluoroquinolones
[51] and to contribute to aminoglycosides resistance [61]. Both
efflux pumps share the same efflux porin, OprM [62]. In P.
aeruginosa, the PhoP-PhoQ two-component regulatory system is
known to be induced upon Mg
2+ starvation to up-regulate the
production of the outer-membrane protein OprH and to increase
the resistance to the polycationic antibiotic polymyxin B [63]. In
addition, PhoP-PhoQ is also involved in resistance to antimicrobial
cationic peptides and aminoglycoside antibiotics [45], in good
agreement with the higher resistance of PAO-SCV to this class of
antibiotics. The arnBCADTEF-PA3559 genes could also be
involved in conferring a higher resistance to aminoglycosides.
Intriguingly, PA3559 encodes a UDP-glucose dehydrogenase that
is induced by low concentrations of Mg
2+ [43] and its expression
depends on the PmrA-PmrB two-component regulatory system,
which is itself regulated by the PhoP-PhoQ two-component system
[64,65,66,67]. The general porin OprF, which is overexpressed in
the SCV, has been recently shown to participate in resistance
mechanisms to a broad spectrum of antibiotics such as b-lactams,
cephalosporins, and fluoroquinolones [68], supporting the role of
OprF as an intrinsic antibiotic resistance contributor as well as
partially explaining the cefotaxime resistance revealed by pheno-
typic assays. Interestingly, we observed a down-regulation of the
cytochrome c ccoN gene (PA4133), which was shown by others to
be involved in small colony variant formation leading to higher
resistance to aminoglycosides [69]. In PAO-SCV we observed a
down-regulation of phage genes compared to the wild-type. The
expression of phage genes has been shown to reciprocally associate
with biofilm formation and antibiotic resistance as evidenced by
Whiteley and colleagues [70]. These authors found that phages
genes were up-regulated in mature biofilms as compared to
planktonic cultures while they were shown to be down-regulated in
biofilms exposed to the aminoglycoside tobramycin. A puzzling
observation is the strong down-regulation in PAO-SCV of PQS
biosynthesis genes and of the PQS-related efflux pump MexGHI-
OpmD [39], which is confirmed by the near absence of PQS
production presented in Figure 3. It has been suggested that high
production of PQS, which results in an autolysis phenotype, could
be explained by the induction of prophages [22], which fits with
the results presented here.
Collectively, our whole genome expression analysis of PAO-
SCV versus wild-type PAO1 allowed us to get a good correlation
between phenotypic traits (antibiotic resistance, PQS and
virulence factors production), proteomic and gene expression
data. Intriguingly, we found only one mutation to be present in the
pseudo-revertant only. This mutation could cause a higher
translation rate of the tufA messenger RNA since it changed a
rarely used GAU codon for aspartate to the more frequently used
GAC. It is also interesting to notice that in the SCV proteome
there was a strong decrease of the TufB protein (Figure 4). In
Salmonella enterica, the translation factor Ef-Tu is also encoded by
two paralogous genes, tufA and tufB, and it has been shown that
mutations in tufB, which impair growth, can be rescued by
compensatory mutations in the RNAse E gene or in tufA [71],
situation similar to what we observed here. However, we have to
be cautious before concluding that the tufA mutation is the only
cause of the reversion associated with a higher growth rate. Our
results do not explain either why the level of the TufB protein is
strongly decreased in the SCV since no changes were found at the
Table 3. List of genetic variations in P. aeruginosa SCV revertant.
Locus
a
Gene
name Product Position
b Nucleotide
Ref.
base
c
variant
base Type Protein effect
d
Position
[AA]
e SCV
f WT
PA0748 mmsR Still frameshift
probable
transcriptional
regulator
816532 425 G C Single
insertion
Frameshift 142 ++
PA1179 phoP Two-component
response
regulator PhoP
1277728 41 A G SNP H-.R exchange 14 + -
PA1180 phoQ Two-component
sensor PhoQ
1279044 683 39 bp
deletion
In frame deletion 228 + -
PA1385 Probable glycosyl
transferase
1505156 552 C T SNP Silent mutation 184 + ND
PA2020 mexZ Probable
transcriptional
regulator
2213076 400 C T SNP Nonsense mutation 134 + -
PA2046-PA2047 Intergenic region 2239547 280 T G SNP + ND
PA2141 Hypothetical
protein
2356684 517 C - Single
deletion
Frameshift 173 ++
PA4265 tufA Elongation
factor Tu
4767985 1020 T C SNP Silent mutation 340 - -
aGene locus, gene name and product description are extracted from Pseudomonas Genome Database (http://www.pseudomonas.com).
bChromosomal position (nt).
cRef. base, reference base.
dChange of protein sequence.
ePosition relative to first amino acid of the protein.
fFound in SCV as well after Sanger sequencing.
ND, not determined.
doi:10.1371/journal.pone.0029276.t003
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of a phenotypic switch without mutation, like the recently
described bi-stable phenotypic switch due to the LysR regulator
BexR [72]. Phenotypic switches have been described in Pseudomo-
nas brassicacearum leading to two types of colonies with different
abilities to colonize plant roots [73]. In rhizosphere pseudomonads
phase variation is commonly observed and in one case the
involvement of GacS/GacA two-component system as well as
MutS and RpoS in phase variation has been described [74,75,76].
However, we could not detect any nucleotide change in gacA/gacS
or in mutS and rpoS, which suggests that the switch has another,
unidentified, origin and excluding the possibility that the SCV
strain has a hypermutator phenotype.
In conclusion, our study demonstrates that the SCV phenotype
could arise due to the accumulation of several mutations and that
the resistance to aminoglycosides expressed by the SCV clone is
multifactorial.
Methods
Bacterial strains and culture conditions
P. aeruginosa PAO1 Strain (ATTC 15692) and its gentamicin-
resistant mutant PAO-SCV were used in this study. P. aeruginosa
strains were grown at 37uC in Luria-Bertani (LB) broth or on LB
agar plates, iron poor casamino acids (CAA) medium (Difco
Laboratories) or Pseudomonas agar medium (Difco Laboratories).
The antibiotics gentamicin (Gm) at 200 mgm l
21 and spectino-
mycin (Sp) at 50 mgm l
21 were used when necessary. Growth rate
of three replicates for each strain was monitored spectrophoto-
metrically (Bioscreen C, Thermo Labsystems).
Motility assay
Swarming, swimming and twitching motility were determined
as previously described [77]. To investigate swarming motility,
4 ml of overnight cultures of P. aeruginosa grown in LB (1610
9 cells)
were placed in the center of 0.4% agar LB or CAA plates while
swimming motility was evaluated using 0.3% agar LB or CAA
plates. For twitching motility, LB or CAA plates containing 1.5%
agar were inoculated with a toothpick by stabbing the plates. The
plates were then incubated at 37uC. In the case of twitching, after
incubation the LB- or CAA-agar media was removed from the
plates and plates were stained with 1% crystal violet (Merck) in
33% acetic acid for a minimum of 20 min. Spreading of bacteria
from the inoculation point was measured and pictures were taken.
Three independent experiments were performed.
Detection and analysis of signal molecules
Rapid detection of N-acyl homoserine lactones (AHLs) in filter
sterilized (0.2 mm pore-size filters) culture supernatants was done
using AHL reporter plate bioassays by either E. coli JM109
carrying the plasmid pSB401 for the detection of N-(butanoyl)-L-
homoserine lactone (C4-HSL) [78] or E. coli MH155 [79] for the
detection of N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-
C12-HSL). For accurate AHL quantification, 100 ml of acidified
filter-sterilized culture supernatants were extracted with equal
volumes of dichloromethane. The organic phase was removed and
dried by evaporation in vacuum. Extracts were re-dissolved in
1 ml of 50% acetonitrile. Thin-layer chromatography (TLC)
plates Silica gel 60 F254 (Merck) and RP-18 F245 (Merck) were used
for detection of 3-oxo-C12-HSL and C4-HSL, respectively.
Twenty ml of extracted AHLs were fractionated on TLC plates.
After development in a solvent mixture of methanol/water (60:40,
vol/vol), the plates were dried and overlaid with 50 ml of soft top
LB-agar mixed with 1 ml of overnight culture of an E. coli MH155
strain harboring the reporter plasmid pUCP22NotI-PlasB::gfp(ASV)-
Plac ::lasR (to detect 3-oxo-C12-HSL) or 1 ml of overnight culture
of E. coli JM109 pSB401 (to detect C4 and C6-HSL). After 18 h
incubation at 37uC the production of 3-oxo-C12-HSL was
detected under UV by visualization of green fluorescent spots
and production of C4 and C6 was visible by the production of
light.
The alkyl-hydroxy quinolones PQS and HHQ were extracted
from 10 ml of early stationary phase filtered supernatants by
adding equal volumes of acidified ethyl acetate. The organic phase
was dried and the residue re-suspended in 50 ml methanol. Ten ml
samples of this extract were spotted onto normal phase silica 60
F254 (Merck) TLC plates, pre-treated by soaking in 5% K2HPO4
for 30 min and activated at 100uC for 1 h. Extracts were
separated using a dichloromethane:methanol (95:5, vol/vol)
solvent system until the solvent front reached the top of the plate.
PQS was visualised under UV light and specific detection was
done using soft top LB-agar including 1 ml of overnight culture of
a P. aeruginosa lecA::lux DpqsA strain as bioreporter [80].
Bioluminescence was detected and quantified with a Bio Imaging
System (Syngene). Amounts of C4-HSL, C6-HSL, 3-oxo-C12-
HSL and PQS were determined by measuring the diameter of the
spots.
Persistence assay
The persistence assay was performed essentially as described
previously [6]. Shortly, cultures were grown overnight at 37uCi n
100 ml LB medium in Erlenmeyer flasks. One mL of a stationary
phase culture was treated with 10 mL of ofloxacin at a final
concentration of 5 mgm L
21; a control treatment was performed
with sterile water. Both treatments were performed at 37uC,
shaking at 200 rpm, during five hours, after which the number of
colony forming units were determined by plate counts. The
persister fraction is defined as the number of surviving cells after
treatment with ofloxacin, divided by the number of cells after the
control treatment. The relative persister fraction for each strain is
the persister fraction of the strain divided by that of the wild-type.
The mean relative persister fraction is calculated as the inverse
logarithm of the mean of the logarithmic values of these relative
persister fractions of separate experiments. The mean relative
persister fractions are displayed with the bars representing the 25
th
and 75
th percentiles as shown in Figure S1. Each experiment was
repeated at least three times.
Proteome analysis by two-dimensional (2D) gel
electrophoresis
P. aeruginosa cells were harvested in early stationary phase by
centrifugation (4,000 g, 10 min, 4uC) and washed three times with
Tris-HCl buffer (pH 8.0). To prepare extracts of cellular proteins,
bacterial cells were washed twice in PBS buffer (pH 8.0) and re-
suspended in a solution containing 40 ml of 2.5 mM Tris-HCl
(pH 8.0), one tablet of protease inhibitor (Sigma), 80 ml of 0.5 M
Na2EDTA, and 400 ml of DNase at 10 mg ml
21. After lysis of the
cells by sonication with a Branson Sonifier 250, each suspension
was centrifuged (2,500 g, 15 min, 4uC) to remove the cell debris
and unbroken cells. The supernatant was then subjected to a
second centrifugation (50,000 g, 40 min, 4uC) to remove the
insoluble components, and the protein concentration in the
resulting supernatant was determined by a Bradford Protein assay
(Bio-Rad). Deoxycholic acid (sodium salt) was added to a final
concentration of 0.2 mg ml
21. After 30 min of incubation on ice,
the proteins were precipitated by addition of 6% (wt/vol)
trichloroacetic acid and incubated at 4uC for 2 hr. After
centrifugation (18,000 g, 30 min, 4uC) the precipitated proteins
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acetone (220uC) were added. After incubation at 220uC for 2 h,
the mixture was centrifuged (3,500 g, 20 min, 4uC), and the pellet
was allowed to dry for 5 min before it was dissolved in an
appropriate amount of solubilisation buffer. After centrifugation
(50,000 g, 40 min, 4uC) to remove the insoluble components, the
protein concentration of the remaining supernatant was deter-
mined. Protein extracts were either used immediately for 2-D gel
electrophoresis or stored at 280uC. Isoelectric focusing was
performed with the IPGphor system and Immobiline DryStrip gel
strips (GE Healthcare). Equal quantities of solubilised proteins
from the different P. aeruginosa strains were diluted to obtain a final
volume of 360 ml with solubilisation solution and applied to the
Immobiline gel strips by in-gel rehydration. Linear immobilized
pH gradients (pH 4 to 7) were used. Thirty to 50 mg of protein was
applied for analytical gels (silver staining), and 200 to 500 mgo f
protein was loaded for Coomassie staining. After rehydration
under silicone oil for 10 hr, the proteins were focused for a total of
120 kV/h at 20uC. The proteins were reduced by equilibration of
the strips in equilibration solution (6 M urea, 30% glycerol, 2%
[wt/vol] sodium dodecyl sulfate, and 1% [wt/vol] dithiothreitol in
0.05 M Tris-HCl (pH 8.8) for 15 min and then carbamidomethy-
lated in the same solution containing 260 mM iodoacetamide for
15 min. The strips were transferred to 12% acrylamide gradient
gels and electrophoresis was performed overnight at 125 V at
10uC. Gels were stained with Coomassie brilliant blue solution and
spots of interest were then further analyzed through peptide mass
fingerprinting according to the described protocol [81]. Peptides
examined on a MALDI-TOF mass spectrometer (Bruker) and
analyzed by MASCOT (Matrix Science) were used to identify
proteins from peptide identifications using the NCBInr database.
Microarray and quantitative real time PCR analysis
Cultures were grown in triplicate until early (24 h) and late
(48 h) stationary phase, respectively, allowing three biological
replicates per condition. Total RNA was obtained from the
cultures of early and late stationary phase by first treating the cells
with RNAprotect Bacteria Reagent (Qiagen) as recommended by
the manufacturer. Cells were then lysed and total RNA was
extracted using the RNeasy Midi Kit (Qiagen), on-column DNase
digestion was performed using the RNase-free DNase Set (Qiagen)
according to the manufactures instructions. RNA integrity was
assessed using the 2100 bioanalyzer (Agilent Technologies Inc.).
cDNA synthesis, fragmentation and labeling were performed
according to the supplier protocol for the P. aeruginosa Genechip
genome array (Affymetrix) at 50uC. Washing and staining of the
arrays was performed according to the manufacturer’s instructions
using a fluidics station 400 (Affymetrix). Slides were scanned using
the 2500A GeneArray Scanner (Agilent Technologies Inc.) and
Affymetrix MAS 5.0. Data analysis was performed using Gene-
Spring GX (Agilent Technologies Inc.) in which the scaled data
was further normalized by per Chip and per Gene median
normalizations. Filtering of genes was performed to find genes that
had changed in expression by a magnitude of 2-fold (P
value,0.05, Student’s t-test).
Bacterial cells were harvested in stationary phase, bacterial
RNA was extracted by using RNeasy Midi Kit (QIAGEN). The
purity and concentration of the RNA was determined by
spectrophotometry (NanoDrop, Thermo Scientific). First-strand
cDNA was reverse transcribed from one microgram of total RNA
by using First-strand cDNA Synthesis Kit (Amersham Biosciences,
GE Healthcare). qRT-PCR was performed in a Bio-Rad
(Hercules, CA, USA) iCycler with Bio-Rad iQ SYBR Green
Supermix. For all primer sets, the following cycling parameters
were used: 94uC for 3 min followed by 40 cycles of 94uC for 30 s,
55uC for 45 s and 72uC for 30 s, followed by 72uC for 7 min. The
outer membrane lipoprotein oprI gene was used to normalize gene
expression [82][82][82][81]. Amplification products were electro-
phoresed on 0.8% agarose gels. For statistical analysis of relative
gene expression, the 2
2ggCT method was used [83]. All
experiments were carried out in triplicate.
Whole genome sequencing
Genomic DNA was isolated from thawed pellets using the
DNeasy Blood & Tissue Kit (Qiagen) according to the manufac-
turer’s instructions. DNA samples were further prepared and
sequenced using paired end sequencing in 76 cycles on a Genome
Analyzer II–X (Illumina). Libraries of 300 bp were prepared
according the manufacturer’s instructions ‘‘Preparing Samples for
Paired-End-Sequencing’’. Cluster generation was performed using
the Illumina cluster station, sequencing for read 1 and read 2 on
the Genome Analyzer followed a standard protocol. The
fluorescent images were processed to sequences using the Genome
Analyzer Pipeline Analysis software 1.3.2 (Illumina).
Sequencing the DNA library resulted in a total number of
12,302,376 read pairs of 2676 nt length. Reads were mapped to
the reference genome of strain PAO1, which was obtained from
the Pseudomonas genome database [84]. The 39-ends of reads were
trimmed using Perl script Trim.pl (http://bioinformatics.ucdavis.
edu/index.php/Trim.pl) with the adaptive window option and a
quality threshold of 10 to remove sequences of low read quality.
Reads pairs containing one or two reads that were trimmed to a
length less than 20 nt were discarded leaving 11,991,338 read
pairs (97.5%). The free license version of Novoalign (www.
novocraft.com) was used for mapping, because this software
includes a gapped alignment algorithm, which improves the
detection of indels [85]. 11,824,266 read pairs (96.1% of the
original reads) were mapped to unique locations resulting in a
median read depth (genome coverage) of 237. Single nucleotide
polymorphisms (SNPs) and indels were detected using the MAQ
software [86] using its built-in functions ‘‘cns2snp’’ and ‘‘indelpe’’,
respectively. Initially, only SNPs with a minimal consensus quality
of 30 and indels that were supported by at least 50% of the reads
overlapping the indel position were considered for further analysis
as potential true positives. All positively filtered SNPs and indels
were checked by visual inspection for correct base/indel calling.
Genomic regions showing a read depth of less than 30 were also
checked by visual inspection for the occurrence of larger indels
that cannot be detected by the combination of Novoalign and
MAQ alone. Furthermore, the confirmation of positives by Sanger
sequencing has been performed and aligned with the sequences
extracted from www.pseudomonas.com.
Additionally, the quality-trimmed read pairs were also assem-
bled de novo using Velvet [87] yielding 1181 contigs with an n50 of
18.4 kbp and maximum length of 83.0 kbp. SNPs and indels were
detected by aligning the contigs to the PAO1 reference genome
using mummer3 [88].
Virulence assays
P. aeruginosa strains were grown overnight in LB medium to
reach stationary phase at 37uC. After centrifugation, bacterial cells
were washed with 10 mM MgSO4 and diluted to 10
8 CFU/ml
and then 10 ml of this suspension were injected with a syringe into
the main vein of Belgian chicory (Cichorium intybus) leaves. The
leaves were placed on dishes containing a Whatman filter
impregnated with sterilized water. The plates were kept in an
incubator at 37uC and watery rot symptoms monitored daily for
72 h.
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(Drosophila melanogaster). Larvae were pricked with needles dipped in
a concentrated suspension of P. aeruginosa strains grown in LB
medium with an absorbance of 1.0 at 600 nm. After pricking, the
larvae were placed in plates containing a piece of paper
impregnated with 10% sugar water. For each condition 20 plates
with 10 larvae were used. During 8 h, the number of dead larvae
was counted every 30 min. A final count was held 24 h after initial
pricking. Data were statistically analyzed by means of repeated
measures ANOVA.
GEO Accession Number: GSE34141
Supporting Information
Figure S1 Mean relative persister fraction of wild-type PAO1
and PAO-SCV after exposure to ofloxacin. See text for details.
(TIF)
Figure S2 Production of virulence factors pyocyanin, pyover-
dine, and elastase (A); motility of wild type PAO1 and PAO-SCV
on swimming (top), swarming (middle), and twitching (bottom)
plates (B); atomic force microscopy images of wild-type and SCV
showing the loss of flagella (C).
(TIF)
Figure S3 Virulence of wild-type, PAO-SCV and revertant (A)
in plants (Cychorium intybus) and (B) of wild-type and PAO-SCV in
Drosophila melanogaster larvae.
(TIF)
Table S1 Number of differentially expressed genes between P.
aeruginosa PAO-SCV and its clonal wild-type PAO1 during
stationary phase.
(DOC)
Table S2 Functional classification of differentially expressed
genes between P. aeruginosa PAO-SCV and its clonal wild-type
PAO1 during stationary phase.
(DOC)
Table S3 Up-regulated genes in P. aeruginosa PAO-SCV
compared to its clonal wild-type PAO1 during stationary phase.
(DOC)
Table S4 Down-regulated genes in P. aeruginosa PAO-SCV
compared to its clonal wild-type PAO1 during stationary phase.
(DOC)
Table S5 Differential expression of selected genes in P. aeruginosa
PAO-SCV compared to its clonal wild-type PAO1 during
stationary phase.
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